Mandate

Vinge advises Tigran Technologies in its new issue

April 29, 2009

Vinge is advising Tigran Technologies AB (publ), listed on AktieTorget, in its new issue of preference shares and warrants subject to pre-emption rights for the existing shareholders.

As a result of the new issue, which is underwritten in its entirety by the principal shareholders and an external syndicate, Tigran will initially receive SEK 20 million as well as up to an additional SEK 30 million in conjunction with full exercise of the warrants.

Vinge’s team was led by Jesper Ottergren who was assisted by, among others, associates Christian Lindhé and Ida Christensson.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025